New Zealand has huge capabilities in growing plants for medicine for the soaring pharmaceutical and consumer health industry, a defining new biotech economic study report says. The landmark BioTechNZ study analysed the state of biotechnology and its impact and benefits for the New Zealand economy and society. New Zealand coupled with its wealth of knowledge …
Continue reading "NZ can play key part in pharmaceutical and consumer health" 
A trailblazing BiotechNZ study just released analyses the state of biotechnology and its impact and benefits for the New Zealand economy and society.
25 November 2020
It highlights the importance of biotech and how it can contribute to New Zealand’s economic growth and diversification, as well as its ability to help make New Zealand cleaner, healthier and more prosperous.
24 November 2020
The landmark BioTechNZ study analysed the state of biotechnology and its impact and benefits for the New Zealand economy and society.
10 November 2020
New Zealand’s first medicinal cannabis summit, MedCan 2020, will take place on Monday and Tuesday this week at the Aotea Centre in Auckland, with over 700 registrations.
09 November 2020
“Alert Level 1 is exciting news for large and important events like ours,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser in response to the Prime Minister’s confirmation that Auckland will join the rest of the country on Level 1 at 12.59pm on Wednesday, 7 October.
05 October 2020
t’s only two months until New Zealand’s first medicinal cannabis summit, MedCan 2020, with organisers saying the economic potential of New Zealand’s most exciting sunrise industry is more important than ever before.
07 September 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis.
18 May 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
08 May 2020
